Pancreatic Cancer Research

ResearcherTongji HospitalActive in the last 2 years

Xianglin Yuan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4653-5388; OpenAlex author ID A5101490524, A5101819324. Sources: ClinicalTrials.gov.

Their work

Papers
4 (first author 0, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 trial · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 4

  1. CXCL11 recruits immunosuppressive cells to form a barrier at the invasive front of pancreatic cancer by activating the NF-κB/CCL2 axis. Last author DOI 10.1016/j.tranon.2026.102909↗
  2. NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial. Co-author DOI 10.1038/s41467-026-68409-0↗
  3. FAM111B and FANCD2, a dual expression signature, defines a distinct phenotype of pancreatic cancer. Co-author DOI 10.1186/s12935-025-03819-6↗
  4. PARP Inhibitor Upregulates PD-L1 Expression and Provides a New Combination Therapy in Pancreatic Cancer. Co-author DOI 10.3389/fimmu.2021.762989↗

Trials 1

  1. Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Chola… Principal investigator NCT06199895↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fang Wei · 2 shared papers, 2025–2026 · strength 0.64
  2. Zuhua Wang · 1 shared paper, 2026 · strength 0.33
  3. Lihong Zhang · 1 shared paper, 2025 · strength 0.30
  4. Yanqiao Zhang · 1 shared paper, 2026 · strength 0.19
  5. Xiuchao Wang · 1 shared paper, 2026 · strength 0.19
  6. Song Gao · 1 shared paper, 2026 · strength 0.19
  7. Chuntao Gao · 1 shared paper, 2026 · strength 0.19
  8. Tiansuo Zhao · 1 shared paper, 2026 · strength 0.19
  9. Chengyou Du · 1 shared paper, 2026 · strength 0.19
  10. Zhihua Li · 1 shared paper, 2026 · strength 0.19
  11. Xiujuan Qu · 1 shared paper, 2026 · strength 0.19
  12. Jihui Hao · 1 shared paper, 2026 · strength 0.19
  13. Rui Liu · 1 shared paper, 2026 · strength 0.19
  14. Yanmei Zou · 1 shared paper, 2021 · strength 0.12
  15. Yali Wang · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.